E. M. Veys

Publication List Details

Period

1975 - 2006

Number

32

Co-Authors

Distinct synovial immunopathologic characteristics of juvenile-onset spondylarthritis and other forms of juvenile idiopathic arthritis (2006)

Kruithof, E., Bossche, V. Van Den, Rycke, L. De, Vandooren, B., Joos, R., Canete, J.D., ...

Objective. To characterize the synovial immunopathologic features of juvenile-onset spondylarthritis (SpA) in relation to adult SpA and other forms of juvenile idiopathic arthritis (JIA). Methods....

Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis (2006)

Kruithof, E., Rycke, L. De, Vandooren, B., Keyser, F. De, FitzGerald, O., McInnes, I., ...

Objective. To identify biomarkers for effective treatment in early-phase clinical trials of spondyl-arthritis (SpA), by analyzing which synovial features can be reliably identified in patients with...

Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis (2006)

Dewint, P., Hoffman, I. E. A., Rogge, S., Joos, R., Union, A., Dehoorne, J., ...

Objectives. Anticitrullinated protein/peptide antibodies (ACPA) have an excellent diagnostic performance for rheumatoid arthritis (RA). Despite similarities between RA and polyarticular juvenile...

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study (2005)

Corluy, L, Veys, E M, De Clerck, L, Peretz, A, ...

OBJECTIVES: To analyse the effect of a dose increase in patients with severe rheumatoid arthritis (RA) with insufficient clinical response to 3 mg/kg infliximab every 8 weeks. METHODS: Patients...

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study (2005)

Durez, P., Corluy, L., Veys, E. M., De Clerck, L., Peretz, A., ...

Objectives. To analyse the effect of a dose increase in patients with severe rheumatoid arthritis (RA) with insufficient clinical response to 3 mg/kg infliximab every 8 weeks. Methods. Patients...

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study (2005)

Durez, P., Corluy, L., Veys, E. M., Clerck, L. De, Peretz, A., ...

Objectives. To analyse the effect of a dose increase in patients with severe rheumatoid arthritis (RA) with insufficient clinical response to 3 mg/kg infliximab every 8 weeks. Methods. Patients...

Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis (2005)

Dewint, P., Hoffman, I. E. A., Rogge, S., Joos, R., Union, A., Dehoorne, J., ...

Objectives. Anticitrullinated protein/peptide antibodies (ACPA) have an excellent diagnostic performance for rheumatoid arthritis (RA). Despite similarities between RA and polyarticular juvenile...

Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy (2003)

Demetter, P, Peeters, M, De Vos, M, Mielants, H, Veys, E M, ...

OBJECTIVES: To investigate whether anti-Saccharomyces cerevisiae antibodies (ASCA), a marker for Crohn's disease (CD), are present in spondyloarthropathies (SpA) and in the subgroups ankylosing...

The Belgian-Flemish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) (2001)

Ruperto, N, Boven, K, Raat, H, Landgraf, J M, ...

We report herein the results of the cross-cultural adaptation and validation into the Belgian-Flemish language of the parent's version of two health related quality of life instruments. The Childhood...

Reparative response of human articular cartilage in tissue culture. Comparison between a normal and an osteoarthritic knee of the same donor (1987)

Verbruggen, G, Veys, E M

Some evidence is presented that the metabolism of visually intact cartilage taken from a knee with focal osteoarthritic lesions, may already be affected. Proteoglycan metabolism of articular...

In vitro repair potential of articular cartilage: proteoglycan metabolism in the different areas of the femoral condyles in human cartilage explants (1987)

Verbruggen, G, Veys, E M, Goffin, E, De Pypere, H

We tested the hypothesis that metabolism of individual cartilage samples, such as those which might be taken at arthroscopy, could reflect the overall intrinsic reparative response of the...

Peripheral blood T lymphocyte subpopulations determined by monoclonal antibodies in active rheumatoid arthritis (1987)

Suykens, S, Veys, E M, Van Lerbeirghe, J, Ackerman, C, Mielants, H, ...

The introduction of an automated flow cytofluorograph has facilitated the detection of T lymphocyte subsets because it enables a larger number of cells to be analyzed. Many authors have reported a...

Repair function in organ cultured human cartilage. Replacement of enzymatically removed proteoglycans during longterm organ culture (1985)

Veys, E M

The effect of enzymatic removal of proteoglycans (PG) from the extracellular matrix of human articular cartilage on subsequent PG metabolism of the remaining chondrocytes was investigated for periods...

N-ACETYL-{beta}-D-GLUCOSAMINIDASE ACTIVITY IN SYNOVIAL FLUID (1975)

VEYS, E. M., GABRIEL, P., DECRANS, L., VERBRUGGEN, G.

N-acetyl-β-D-glucosaminidase activity in the synovial fluid of different articular diseases was studied and statistical investigations were carried out after logarithmic transformation of the data....

Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis

Veys, E. M., Huskisson, E. C., Rosenthal, M., Vischer, T. L., Mielants, H., Thrower, P. A., ...

The effect of thymopoietin pentapeptide (TP-5) was evaluated in patients with rheumatoid arthritis (RA). Ninety-two patients were divided into 3 groups, namely, placebo, TP-5 intramuscularly (IM) 1...

Expression of T cell receptors alpha beta and gamma delta in the ileal mucosa of patients with Crohn's disease and with spondylarthropathy.

Cuvelier, C A, De Wever, N, Mielants, H, De Vos, M, Veys, E M, Roels, H

The expression of the alpha beta and gamma delta heterodimer of the T cell receptor (TCR) was studied in normal human ileal mucosa or in ileal biopsies featuring Crohn's disease or acute and chronic...

CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients

Cruyssen, B Vander, Peeters, H, Hoffman, I E A, Laukens, D, Coucke, P, Marichal, D, ...

Carriage of CARD15 gene polymorphisms and the serological marker anti-Saccharomyces cerevisiae antibodies (ASCA) are two markers for Crohn's disease (CD). Similar phenotypes have been associated with...

The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome

Van Damme, N, De Keyser, F, Demetter, P, Baeten, D, Mielants, H, Verbruggen, G, ...

T lymphocytes and their cytokines have an important role in the regulation of immune responses in the gut and in the pathogenesis of intestinal inflammation such as in Crohn's disease. The aim of...